 |
1 Product |  |
0 Diseases | | 1 Product |
|
0 Trials |  |
2 News |  |
- | EOC317 / EddingPharm
Trial primary completion date, Metastases: Study of EOC317 in Chinese Patients With Advanced Solid Tumors (clinicaltrials.gov) - Sep 11, 2019
P1, N=140, Recruiting, Sponsor: EddingPharm Oncology Co., LTD.
Trial primary completion date: May 2019 --> Feb 2020
- | EOC317 / EddingPharm
New P1 trial, Metastases: Study of EOC317 in Chinese Patients With Advanced Solid Tumors (clinicaltrials.gov) - Jul 15, 2018
P1, N=140, Recruiting, Sponsor: EddingPharm Oncology Co., LTD.